New Flu Vaccines Could Reduce Hospital Admissions
New Flu Vaccines could Significantly Reduce Hospitalizations, Says Health Council
Could new flu vaccines be the key to fewer hospitalizations this flu season? The Health Council, a leading advisory body, believes so. They’ve reviewed four updated flu vaccines and found that two offer older adults 10 to 30 percent greater protection against flu-related hospitalizations compared to current vaccines.
While the third variant shows promise, the council states that the improvement isn’t substantial enough to declare a clear preference.
Targeting High-Risk Groups
The council’s experts analyzed four updated vaccines, focusing on their potential for annual vaccination campaigns. One vaccine, based on cell cultures, lacked sufficient data for a conclusive assessment.
The other updated vaccines utilize higher antigen doses or include adjuvants to enhance effectiveness.The Health Council sees particular value in these newer types for individuals aged 50 and older, who are at higher risk for flu complications.
Looking Ahead: mRNA Vaccines on the Horizon
Pharmaceutical companies are actively developing even more innovative flu vaccines. Notably, mRNA vaccines, similar to those used against COVID-19, are in development, promising protection against both flu and coronavirus.
Flu Shots: A Vital Tool for Prevention
In the United States, everyone aged 60 and older is eligible for the annual flu shot. Individuals with underlying health conditions that increase their risk of flu complications are also strongly encouraged to get vaccinated.Vaccination significantly reduces the likelihood of severe illness, including hospitalization for pneumonia and other complications.
New Flu Vaccines Could Significantly Reduce Hospitalizations
NewsDirectory3.com – Could new flu vaccines be the key to fewer hospitalizations this flu season? The Health Council, a leading advisory body, believes so. They’ve reviewed four updated flu vaccines and found that two offer older adults 10 to 30 percent greater protection against flu-related hospitalizations compared to current vaccines.
While the third variant shows promise, the council states that the enhancement isn’t substantial enough to declare a clear preference.
The council’s experts analyzed four updated vaccines,focusing on their potential for annual vaccination campaigns. One vaccine, based on cell cultures, lacked sufficient data for a conclusive assessment.
The other updated vaccines utilize higher antigen doses or include adjuvants to enhance effectiveness. The Health Council sees particular value in these newer types for individuals aged 50 and older, who are at higher risk for flu complications.
Pharmaceutical companies are actively developing even more innovative flu vaccines. Notably, mRNA vaccines, similar to those used against COVID-19, are in progress, promising protection against both flu and coronavirus.
In the United States, everyone aged 60 and older is eligible for the annual flu shot.Individuals with underlying health conditions that increase their risk of flu complications are also strongly encouraged to get vaccinated. Vaccination significantly reduces the likelihood of severe illness, including hospitalization for pneumonia and other complications.